AzTrials
AzTrials

Femoroacetabular ImpingementNCT04968301

Cross-sectional Study of Ultrasonic Diagnosis of Iliac Joint Capsule Muscle

An observational study of Femoroacetabular Impingement and Hip Developmental Dysplasia, run by Peking University Third Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In order to investigate the relationship between the iliac joint capsular muscle and the development of the hip joint, this study used ultrasound Doppler to measure the anatomical circumference of the iliac joint capsular muscle to explore the relationship Read more about this study

Who is it for?
Ages 20 to 50 yearsHealthy volunteers can take part
What is being tested?
ultrasound Doppler
Type of treatment
Medical device
How many people
132 participants
Where
1 siteChina
Study dates
1 Mar 2019to 30 Oct 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Patients who were admitted to the sports medicine outpatient department of Peking University Third Hospital for hip surgery and volunteers recruited as control group,including 40 patients with developmental dysplasia of the hip 40 femoroacetabular impingement patients and 40 healthy volunteers as the control group.

Who may be able to join

  • ≥ 20 years;
  • Clinically suspected of DDH or Pincer and underwent surgery
  • Understand and sign the informed consent

Who cannot join

  • Leggcalve´-Perthes disease
  • Muscle diseases
  • Hip development disorder
  • History of progressive osteoarthritis
  • History of hip surgery
  • History of arthritis of the hip joint
  • With pacemaker or metal in the body

Trial locations and contacts

1 site in 1 country.

China1 site
  • Department of Ultrasound Diagnosis, Peking University Third Hospital

    Beijing, Beijing Municipality

Other trials in China

About this study

Official title: A Cross-sectional Study: the Development of the Hip Joint Was Studied by Measuring the Anatomical Circumference of the Capsular Muscle of the Iliac Joint With Ultrasound Doppler

In order to investigate the relationship between the iliac joint capsular muscle and the development of the hip joint, this study used ultrasound Doppler to measure the anatomical circumference of the iliac joint capsular muscle to explore the relationship

Read the detailed description

In order to investigate the relationship between the iliac joint capsular muscle and the development of the hip joint, this study used ultrasound Doppler to measure the anatomical circumference of the iliac joint capsular muscle to explore the relationship.Ultrasound was used to compare the size of the iliac joint cystic muscle in the three groups: patients with developmental dysplasia of the hip (DDH), patients with Pincer type femoral hip impingement, and normal control group. The shear wave velocity and shear modulus of the iliac joint capsular muscle of three groups were compared to compare the degree of fat infiltration in muscle.

Being tested
ultrasound Doppler
Medical subject headings
Femoracetabular Impingement, Developmental Dysplasia of the Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasound DopplerDevice

    A cross-sectional study:the development of the hip joint was studied by measuring the anatomical circumference of the capsular muscle of the iliac joint with ultrasound Doppler

Study groups in NCT04968301
Study groupRoleWhat they receive
hip developmental dysplasia grouppatients with developmental dysplasia of hip
Receives: Device: ultrasound Doppler
femoroacetabular impingement grouppatients with femoroacetabular impingement
Receives: Device: ultrasound Doppler
control grouphealthy volunteers
Receives: Device: ultrasound Doppler

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parameter of ultraphonic results

    The anatomical circumference of the capsular muscle of the iliac joint was measured by ultrasound Doppler,including the dimensional ultrasonic gram and shear wave elasticity diagram

    Measured: Ultraphonic was conducted when patients were included in the study from March to October, 2019

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2021
  2. Study start1 Mar 2019
  3. Primary completion30 Aug 2019
  4. Study completion30 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
132 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04968301
Sponsor's protocol ID
M2019122
Status last verified
Jun 2021
First submitted
2 Jul 2021
Last updated
20 Jul 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Femoroacetabular Impingement and Hip Developmental Dysplasia, run by Peking University Third Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Parameter of ultraphonic results (time frame: Ultraphonic was conducted when patients were included in the study from March to October, 2019). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in